THTX (Theratechnologies) Total Liabilities : $78.61 Mil (As of Nov. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Total Liabilities?

Theratechnologies's Total Liabilities for the quarter that ended in Nov. 2024 was $78.61 Mil.

Theratechnologies's quarterly Total Liabilities declined from May. 2024 ($93.42 Mil) to Aug. 2024 ($89.39 Mil) and declined from Aug. 2024 ($89.39 Mil) to Nov. 2024 ($78.61 Mil).

Theratechnologies's annual Total Liabilities declined from Nov. 2022 ($115.83 Mil) to Nov. 2023 ($98.64 Mil) and declined from Nov. 2023 ($98.64 Mil) to Nov. 2024 ($78.61 Mil).

Theratechnologies Total Liabilities Historical Data

The historical data trend for Theratechnologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Total Liabilities Chart

Theratechnologies Annual Data

Trend

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Nov24

Total Liabilities

Get a 7-Day Free Trial

96.92

101.45

115.83

98.64

78.61

Theratechnologies Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Total Liabilities	Get a 7-Day Free Trial															98.64	96.69	93.42	89.39	78.61

Theratechnologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Theratechnologies's Total Liabilities for the fiscal year that ended in Nov. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	36.861	+	(41.73	+	0.021000000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	78.61

Total Liabilities	=	Total Assets (A: Nov. 2024 )	-	Total Equity (A: Nov. 2024 )
	=	53.34	-	-25.272
	=	78.61

Theratechnologies's Total Liabilities for the quarter that ended in Nov. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	36.861	+	(41.73	+	0.021000000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	78.61

Total Liabilities	=	Total Assets (Q: Nov. 2024 )	-	Total Equity (Q: Nov. 2024 )
	=	53.34	-	-25.272
	=	78.61

Theratechnologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

TQ80:Germany TH:Canada

Address

2015, rue Peel, 11th Floor, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.